Earnings News

Latest earnings news and updates for US-listed public companies.

📣 Get earnings alerts and analysis

Repare Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results

CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a clinical-stage precision oncology company, today reported financial results for ...

What is the market's perception of Repare's strategic direction and its long‑term shareholder value creation? How does the company's updated guidance for 2025 revenue and expenses compare to prior guidance? Are there any regulatory or clinical trial risks associated with the newly out‑licensed programs?
Symbol: RPTX
26 days ago
Read more businesswire

NHC Reports Second Quarter 2025 Earnings

MURFREESBORO, Tenn.--(BUSINESS WIRE)--National HealthCare Corporation (NYSE American: NHC), the nation's oldest publicly traded senior health care company, announced today net operating revenues fo...

How does the reported sentiment score of 70 align with analyst sentiment and investor sentiment for NHC? Could the strong revenue performance trigger any strategic initiatives, such as acquisitions or expansion plans? What is the market's perception of the company's growth trajectory—are analysts upgrading or downgrading the stock?
Symbol: NHC
26 days ago
Read more businesswire

Dentalcorp Reports Second Quarter 2025 Results

TORONTO--(BUSINESS WIRE)--dentalcorp Holdings Ltd. (“Dentalcorp” or the “Company”) (TSX: DNTL), Canada’s largest and one of North America’s fastest growing networks of dental practices, today annou...

Is there any new information on cash flow, capital expenditures, or debt that could impact the company's financial health? What macro or sector-specific risks could affect Dentalcorp's ability to achieve its full-year guidance? How might the Q2 results influence investor sentiment and trading volume in the short term?
Symbol: DNTL
26 days ago
Read more businesswire

Surmodics Reports Third Quarter of Fiscal Year 2025 Financial Results; Updates Fiscal Year 2025 Financial Guidance

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial ...

What short‑term technical implications might this news have on the stock’s price action and trading volume? Are there any upcoming regulatory milestones, product launches, or contracts that could offset the current revenue decline? Will the revised guidance materially affect the company's valuation multiples (e.g., P/E, EV/Revenue)?
Symbol: SRDX
26 days ago
Read more businesswire

Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results

CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bi...

What macro or sector trends (e.g., biotech funding environment, interest rates) could impact the company's ability to raise capital or achieve growth targets? How might the sentiment score of 30 (relatively neutral) influence short‑term price movement, and what technical patterns are emerging? Is there any indication of partnership or collaboration activity with larger pharmaceutical companies that could de‑risk future development?
Symbol: BCYC
26 days ago
Read more businesswire

THE WENDY'S COMPANY REPORTS SECOND QUARTER 2025 RESULTS

Global systemwide sales were $3.7 billion, a decrease of 1.8% International systemwide sales grew 8.7% with growth across all regions Added 26 net new restaurants and remain on track to deliver ful...

How might the market react to the combination of modest unit growth and mixed sales trends in terms of price momentum? Are there any operational or cost‑structure initiatives underway that could offset the global sales decline? What guidance, if any, did management provide for FY2025 earnings and same‑store sales growth?
Symbol: WEN
26 days ago
Read more prnewswire

Nano Labs to Announce First Half of Fiscal Year 2025 Financial Results on August 15, 2025

HONG KONG, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Nano Labs Ltd (Nasdaq: NA) (“we,” the “Company” or “Nano Labs”), a leading Web 3.0 infrastructure and product solution provider, today announced that ...

Could the earnings results trigger any changes in institutional ownership or short‑interest levels? What is the historical pattern of Nano Labs' stock movement around similar earnings releases, and can that inform a trading strategy? Are there any upcoming catalysts (e.g., product launches, partnerships, token listings) that could amplify the impact of the earnings on the stock?
Symbol: NA
26 days ago
Read more globenewswire

Gencor Releases Third Quarter Fiscal 2025 Results

ORLANDO, Fla., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Gencor Industries, Inc. (the “Company” or “Gencor”) (NYSE American: GENC) announced today net revenue increased 5.6% for the quarter ended June 30...

Could the revenue growth trigger any technical chart patterns or trigger stop‑loss orders for existing positions? What is the market's reaction to the earnings surprise, and does it indicate a shift in investor sentiment toward Gencor? How does the current valuation (e.g., P/E, EV/EBITDA) of Gencor compare to its historical averages and to competitors after this earnings release?
Symbol: GENC
26 days ago
Read more globenewswire

TeraWulf Reports Second Quarter 2025 Results

On schedule and on budget to deliver 72.5 MW of gross HPC hosting infrastructure to Core42 in 2025.

What is the expected impact on the company's balance sheet, particularly cash flow and capital expenditures, after completing the Core42 deployment? How might the sentiment score of 60 translate into market perception and short‑term price momentum? What macro‑economic or regulatory factors could influence the valuation of WULF following this earnings release?
Symbol: WULF
26 days ago
Read more globenewswire